Deb Geraghty is the founder of Radiant Biotherapeutics. Radiant Biotherapeutics has raised $45M in total funding. Latest round: Series A.
Deborah (Deb) Geraghty, Ph.D., was appointed President and Chief Executive Officer of Radiant Biotherapeutics in July 2025, following the company's $35 million Series A financing. She is a biotechnology executive leading Radiant's therapeutic pipeline built on its proprietary Multabody™ antibody platform. Prior to this role, she was not listed as a founding executive; the company was founded in 2020 by Amplitude Ventures with Jo Hulme, Ph.D., as founding Chief Scientific Officer.
Full founder directory · Investor directory · Company funding database · Fundraising library